| Literature DB >> 31449073 |
Rajiv Reddy, Rupa Prasad, Sepehr Rejai1, Kenneth Halter, Jeffrey Chen.
Abstract
Transverse myelitis (TM) is a rare neurologic disorder of acute inflammation resulting in spinal cord injury. Chronic pain in TM is a significant detriment to quality of life. Spinal cord stimulation (SCS) is an emerging treatment that has shown significant efficacy in neuropathic pain. We present a 37-year-old man with a history of idiopathic thoracic TM and refractory chronic neuropathic pain who underwent an SCS trial. He reported 70% improvement during the trial and was subsequently implanted with an SCS. He continues to experience significant pain relief and functional improvement (>80%) with conventional paresthesia programming at the 9-month follow-up.Entities:
Mesh:
Year: 2019 PMID: 31449073 PMCID: PMC7017750 DOI: 10.1213/XAA.0000000000001078
Source DB: PubMed Journal: A A Pract ISSN: 2575-3126